Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.

× No keyword cloud information.

12 in total

1. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors: P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal: Lancet Date: 1989-01-28 Impact factor: 79.321

2. The natural history of lone atrial fibrillation. A population-based study over three decades.

Authors: S L Kopecky; B J Gersh; M D McGoon; J P Whisnant; D R Holmes; D M Ilstrup; R L Frye
Journal: N Engl J Med Date: 1987-09-10 Impact factor: 91.245

3. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

Authors: F J van der Meer; F R Rosendaal; J P Vandenbroucke; E Briët
Journal: Arch Intern Med Date: 1993-07-12

4. Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors: W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal: N Engl J Med Date: 1982-04-29 Impact factor: 91.245

5. Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Authors: E M Hylek; D E Singer
Journal: Ann Intern Med Date: 1994-06-01 Impact factor: 25.391

6. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.

Authors: M D Ezekowitz; S L Bridgers; K E James; N H Carliner; C L Colling; C C Gornick; H Krause-Steinrauf; J F Kurtzke; S M Nazarian; M J Radford
Journal: N Engl J Med Date: 1992-11-12 Impact factor: 91.245

Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.

1. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

2. The natural history of lone atrial fibrillation. A population-based study over three decades.

3. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

4. Epidemiologic features of chronic atrial fibrillation: the Framingham study.

5. Risk factors for intracranial hemorrhage in outpatients taking warfarin.

6. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.

7. Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.

8. The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study.

9. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

10. Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.